Manufacturing growth sees surging demand at CPhI South East Asia

3 May 2019

Number of visitors seeking a contract manufacturer was extremely high, with multinational corporations increasingly looking for local partners to expedite market access into the wider region.

SE Asian demand for manufacturing is being driven by recent regulatory changes and increased generics from Indonesia, Malaysia and the Philippines. These prosperous regional conditions were in evidence at the largest ever CPhI South East Asia (8th edition), which closed late last month. The event’s move from Indonesia to Thailand was extremely successful, with the new Bangkok location booming in just its first year of operation.

Manufacturing growth sees surging demand at CPhI South East Asia

One of the emerging trends reported by exhibitors was the increased internationalisation, and this was a common theme running throughout the show, whether it was content from sessions about the FDA Framework and requirements for importing APIs to an increased number of regional distributors. In addition, the number of visitors seeking a contract manufacturer was extremely high, further indicative of the internationalisation of the ASEAN pharma industry, with multinational corporations increasingly looking for local partners to expedite market access into the wider region.

The ASEAN’s market is widely expected to see robust growth through 2019 into 2020 in part thanks to its diversity of opportunity. The region features a good mix of rapidly gentrifying healthcare economies in Thailand and Vietnam, coupled advanced economies with significant high-value manufacturing in Singapore, as well as large patient population countries with an ever increasing demand for generics in Malaysia, Indonesia and Philippines.

Often seen as an indicator of ASEAN pharma’s overall health, the success of CPhI South East Asia suggests a thriving pharma sector in the region. Indicative of this region’s overall prosperity, the show has seen an increase of more than 50% in attendees, with almost 7,250 unique attendees and more than 250 exhibitors over 3 days. Such was the strength of the show’s new country, CPhI South East Asia will be moving to the IMPACT, Muang Thong Thani in Bangkok next year where event organisers anticipate an even larger offer onsite and more international visitors.

“It was such a successful edition. The ASEAN pharma market is one that is now brimming with potential and is already reaping the rewards of recent regulatory reforms. CPhI South East Asia has established itself as the region’s business hub, attracting everyone from ingredient suppliers to distributors and CMOs, coming from an increasing diverse range of countries. What is most rewarding is that this show has been integral to industry growth over the last year, with the constant exchanging of ideas and widening business networks playing a pivotal role,” said Marie Lagrenee, Brand Manager at CPhI South East Asia.

In 2020, CPhI South East Asia will co-locate with FDF, ICSE, P-MEC, InnoPack, and NEX South East Asia with Informa expecting to welcome more than 6,000 attendees and 275 exhibitors. Executives attend from across the region’s fastest growing pharma segments, with packaging experts, machinery providers and contract manufacturing, as well as an emerging nutraceutical and laboratory sector – facilitating a collective environment that is helping sustain the next stage in the ASEAN pharma expansion.

Read More

Related news

Expert forecasts huge growth in Middle East manufacturing

Expert forecasts huge growth in Middle East manufacturing

16 May 2019

UAE consumers and insurance companies are willing to pay for highest quality drug products.

Read more 
Lessons learned from early EU FMD adopters

Lessons learned from early EU FMD adopters

13 May 2019

Data exchange, investment costs, resources and hardware identified as some of the biggest challenges.

Read more 
Sirio’s Ayanda launches probiotic softgel

Sirio’s Ayanda launches probiotic softgel

23 Apr 2019

Patent-pending technology is the first ever to enable a softgel capsule to contain both probiotic bacteria and Omega 3 oil.

Read more 
Surge of Indian biosimilars market forecast in 2019

Surge of Indian biosimilars market forecast in 2019

22 Apr 2019

India predicted to be one of the world’s ‘fastest growing bio’ hubs in 2019, fuelled by new biosimilars production.

Read more 
New China-based biotechs fueling growth in manufacturing across China

New China-based biotechs fueling growth in manufacturing across China

9 Apr 2019

New guidelines will see poorer quality manufacturers drop out of the market.

Read more 
BASF launches three new active ingredients derived from the rambutan tree

BASF launches three new active ingredients derived from the rambutan tree

2 Apr 2019

The ingredients are extracted from the first organically certified rambutan gardens in Vietnam.

Read more 
Japanese R&D reinvigorated with international partnerships proliferating

Japanese R&D reinvigorated with international partnerships proliferating

26 Mar 2019

Generics consumption increasing, and the removal of long-list products is opening up funding towards true innovation.

Read more 
Sizeable growth potential for global drug delivery and packaging in 2019

Sizeable growth potential for global drug delivery and packaging in 2019

19 Mar 2019

Patient-centricity, eco-friendly and smart packaging trends marked as the biggest growth drivers and innovations in 2019.

Read more 
Third Sartorius Research Xchange Forum 2019 focuses on CAR-T cell therapy

Third Sartorius Research Xchange Forum 2019 focuses on CAR-T cell therapy

13 Mar 2019

Event for experts from academia and industry, including talks, live demo sessions, and panel discussion.

Read more 
Overcoming lyophilization challenges at Interphex 2019

Overcoming lyophilization challenges at Interphex 2019

10 Mar 2019

Line of Sight approach to freeze-drying enables organizations to bring pharmaceutical products safely and quickly to market.

Read more